Leadership Change

Elevara Medicines taps biotech veteran Dr. Mai-Britt Zocca to lead its charge against rheumatoid arthritis with a novel drug and $70M in backing.

With a new CEO from the world of high-stakes mining finance, Entrée Resources signals a strategic pivot for its stake in the massive Oyu Tolgoi copper mine.

Lawson Whiting's retirement triggers a CEO search at the spirits giant. His legacy of premiumization meets a sobering market for his successor.

Eupraxia Pharmaceuticals is overhauling its leadership and relocating to major biotech hubs, betting it all on its late-stage pipeline and a pivotal trial.

Astrana Health is betting big on two veteran executives to scale its AI-driven model. This move isn't just about growth—it's about execution in a booming market.

With the strategic hire of top-rated analyst Garik Shmois, D.A. Davidson signals a major push to dominate research in the critical construction sector.

Tech holding company Anshar Labs acquires 18-year-old Dealer World, betting that its deep AI engineering can transform an industry drowning in noise.

SAFCO promotes a capital markets expert as President, signaling an aggressive, tech-fueled plan to expand auto financing for America's 'credit invisible'.

MAX Surgical names its founder, Dr. Jason Auerbach, CEO. The move signals a new phase of growth, testing if a surgeon-led model can scale without losing its soul.

Dr. Sydney C. Butts, a leading facial plastic surgeon, joins ENT & Allergy Associates, bringing world-class reconstructive and aesthetic care to Brooklyn.

With Melissa Milstead as CLO, Ericsson Federal fortifies its compliance framework to accelerate the delivery of secure 5G and AI tech to the U.S. government.

Pete Pacelli's rise to Managing Director isn't just a personnel move. It's a strategic signal of Granite Creek’s deepening investment in agribusiness.

Ally Financial poaches a top tech leader from Capital One, betting on Mark Mathewson's AI and cloud expertise to secure its dominance in digital finance.

ECI Group’s appointment of Thomas Rowe isn’t just a new hire; it’s a strategic move to master the complexities of a cooling multifamily real estate market.

With cash dwindling, Workhorse brings in capital-raising specialist Jody Davis. Can a new financial architect secure the future for this EV hopeful?

The ad tech giant adds a Google and LinkedIn veteran to its board, a calculated move to deepen its AI expertise and champion the open internet amid market headwinds.

With a new CMO, $50M in fresh capital, and pivotal trials on the horizon, Cue Biopharma makes a strategic bet on an immunology veteran to guide its future.

Dextra Partners' new VP isn't just a new hire; he's a signal. We deconstruct why firms are now hunting for 'full toolkit' talent to build resilient firms.

By hiring top drug and deal makers, Bexorg signals its AI-powered human brain platform is ready to move from a bold experiment to a commercial powerhouse.

o9 Solutions' promotion of an insider as COO isn't a simple C-suite shuffle. It's a clear signal of its ambition to move beyond AI tech to redefine how companies operate.